Literature DB >> 30787125

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Matthew P Goetz1, William J Gradishar2, Benjamin O Anderson3, Jame Abraham4, Rebecca Aft5, Kimberly H Allison6, Sarah L Blair7, Harold J Burstein8, Chau Dang9, Anthony D Elias10, William B Farrar11, Sharon H Giordano12, Lori J Goldstein13, Steven J Isakoff14, Janice Lyons4, P Kelly Marcom15, Ingrid A Mayer16, Meena S Moran17, Joanne Mortimer18, Ruth M O'Regan19, Sameer A Patel13, Lori J Pierce20, Elizabeth C Reed21, Hope S Rugo22, Amy Sitapati7, Karen Lisa Smith23, Mary Lou Smith24, Hatem Soliman25, Melinda L Telli6, John H Ward26, Jessica S Young27, Dorothy A Shead28, Rashmi Kumar28.   

Abstract

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.
Copyright © 2019 by the National Comprehensive Cancer Network.

Entities:  

Year:  2019        PMID： 30787125     DOI： 10.6004/jnccn.2019.0009

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  61 in total

1.  Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach.

Authors:  Jennifer Y Sheng; Cesar A Santa-Maria; Neha Mangini; Haval Norman; Rima Couzi; Raquel Nunes; Mary Wilkinson; Kala Visvanathan; Roisin M Connolly; Evanthia T Roussos Torres; John H Fetting; Deborah K Armstrong; Jessica J Tao; Lisa Jacobs; Jean L Wright; Elissa D Thorner; Christine Hodgdon; Samantha Horn; Antonio C Wolff; Vered Stearns; Karen L Smith
Journal:  JCO Oncol Pract       Date:  2020-06-30

2.  18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients.

Authors:  Panli Li; Xiuying Wang; Chongrui Xu; Cheng Liu; Chaojie Zheng; Michael J Fulham; Dagan Feng; Lisheng Wang; Shaoli Song; Gang Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-25       Impact factor: 9.236

3.  Opportunities for improving cancer treatment using systems biology.

Authors:  Jason I Griffiths; Adam L Cohen; Veronica Jones; Ravi Salgia; Jeffrey T Chang; Andrea H Bild
Journal:  Curr Opin Syst Biol       Date:  2019-11-27

Review 4.  Management of hormone receptor-positive, HER2-negative early breast cancer.

Authors:  Elaine M Walsh; Karen L Smith; Vered Stearns
Journal:  Semin Oncol       Date:  2020-06-03       Impact factor: 4.929

5.  17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study.

Authors:  Lindsay J Collin; Sinna P Ulrichsen; Thomas P Ahern; Michael Goodman; Lauren E McCullough; Lance A Waller; Kristina Bang Christensen; Per Damkier; Stephen Hamilton-Dutoit; Kristina L Lauridsen; Rami Yacoub; Peer M Christiansen; Bent Ejlertsen; Henrik Toft Sørensen; Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Acta Oncol       Date:  2019-10-31       Impact factor: 4.089

Review 6.  Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.

Authors:  Kaustav Bera; Kurt A Schalper; David L Rimm; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Nat Rev Clin Oncol       Date:  2019-08-09       Impact factor: 66.675

7.  The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients.

Authors:  C van Dooijeweert; I O Baas; I A G Deckers; S Siesling; P J van Diest; E van der Wall
Journal:  Breast Cancer Res Treat       Date:  2021-01-30       Impact factor: 4.872

8.  Pan-cancer analysis of prognostic metastatic phenotypes.

Authors:  Nicholas G Zaorsky; Xi Wang; Sara M Garrett; Eric J Lehrer; Christine Lin; David J DeGraff; Daniel E Spratt; Daniel M Trifiletti; Amar U Kishan; Timothy N Showalter; Henry S Park; Jonathan T Yang; Vernon M Chinchilli; Ming Wang
Journal:  Int J Cancer       Date:  2021-08-27       Impact factor: 7.396

9.  Variation of Long Non-Coding RNA And mRNA Profiles in Breast Cancer Cells With Influences of Adipocytes.

Authors:  Xin-Hui Cao; Kai Yang; Ming-Xing Liang; Pei Ma; Di Xu; Yin-Jiao Fei; Wei Zhang; Xiu Chen; Jin-Hai Tang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  Assessment of myocardial extracellular volume on body computed tomography in breast cancer patients treated with anthracyclines.

Authors:  Caterina Beatrice Monti; Moreno Zanardo; Tommaso Bosetti; Marco Alì; Elena De Benedictis; Alberto Luporini; Francesco Secchi; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.